Cite
HARVARD Citation
Al-Bawardy, B. et al. (2019). Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease. Inflammatory bowel diseases. 25 (3), pp. 580-586. [Online].